154
Participants
Start Date
November 30, 2012
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Intravitreal Aflibercept Injection (IAI)
Phoenix
Tucson
Beverly Hills
Oakland
Palm Desert
Sacramento
Santa Ana
Westlake Village
Colorado Springs
Golden
Boynton Beach
Fort Lauderdale
Fort Myers
Pensacola
Plantation
Tampa
Winter Haven
Augusta
Oak Park
New Albany
Wichita
Lexington
Boston
Worcester
Jackson
Lincoln
Las Vegas
Portsmouth
Bloomfield
Lawrenceville
Northfield
Teaneck
Rochester
Asheville
Oklahoma City
Portland
Salem
Kingston
Pittsburgh
Florence
Ladson
West Columbia
Rapid City
Nashville
Arlington
Fort Worth
Houston
San Antonio
Seattle
Regeneron Pharmaceuticals
INDUSTRY